Clinical Trial Update: Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing genotype-guided abbreviated dual antiplatelet therapy to unguided de-escalation therapy in acute coronary syndrome patients und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Samsung Medical Center | Conditions: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), High Bleeding Risk | Phase 4 | Status: NOT_YET_RECRUITING